These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9374946

  • 1. Ticlopidine-associated pancytopenia: implications of an acetylsalicylic acid alternative.
    Gill S, Majumdar S, Brown NE, Armstrong PW.
    Can J Cardiol; 1997 Oct; 13(10):909-13. PubMed ID: 9374946
    [Abstract] [Full Text] [Related]

  • 2. [Pancytopenia caused by ticlopidine treated with filgrastim. Description of a case].
    Tursi A, Modeo ME, Cuccorese G, Cascella AM, Spinazzola AM, Miglietta A.
    Recenti Prog Med; 2000 Oct; 91(10):511-2. PubMed ID: 11072739
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Agranulocytosis associated with ticlopidine: a possible benefit with filgastim.
    Marinella MA.
    Ann Clin Lab Sci; 1997 Oct; 27(6):418-21. PubMed ID: 9433539
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 9. Clopidogrel resistance?
    Gurbel PA, Tantry US.
    Thromb Res; 2007 Feb; 120(3):311-21. PubMed ID: 17109936
    [Abstract] [Full Text] [Related]

  • 10. [Ticlopidine-induced pancytopenia: therapy of agranulocytosis with granulocyte colony stimulating factor].
    Schneider AW, Fechler L, Gilfrich HJ.
    Med Klin (Munich); 1996 Jun 15; 91(6):417-9. PubMed ID: 8767319
    [No Abstract] [Full Text] [Related]

  • 11. Ticlopidine induced agranulocytosis managed with granulocyte colony stimulating factor.
    Thomson LE, Stewart JT.
    N Z Med J; 1998 Mar 13; 111(1061):81-2. PubMed ID: 9549559
    [No Abstract] [Full Text] [Related]

  • 12. Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases.
    Symeonidis A, Kouraklis-Symeonidis A, Seimeni U, Galani A, Giannakoulas N, Fragopanagou E, Tiniakou M, Matsouka P, Zoumbos N.
    Am J Hematol; 2002 Sep 13; 71(1):24-32. PubMed ID: 12221670
    [Abstract] [Full Text] [Related]

  • 13. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct 13; 18(103):193-5. PubMed ID: 19877380
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel-induced hypersensitivity syndrome associated with febrile pancytopenia.
    Comert A, Akgun S, Civelek A, Kavala M, Sarigül S, Yildirim T, Arsan S.
    Int J Dermatol; 2005 Oct 13; 44(10):882-4. PubMed ID: 16207199
    [No Abstract] [Full Text] [Related]

  • 15. [Transient pancytopenia due to ticlopidine--a case report].
    Grabowski M, Barg W, Biełous-Wilk A, Kopec A, Chmielowicz B, Panaszek B.
    Pol Arch Med Wewn; 2005 Oct 13; 114(4):974-7. PubMed ID: 16789523
    [Abstract] [Full Text] [Related]

  • 16. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH, Bhatt DL, Fox KA, Steinhubl SR, Brennan DM, Hacke W, Mak KH, Pearson TA, Boden WE, Steg PG, Flather MD, Montalescot G, Topol EJ, CHARISMA Investigators.
    Eur Heart J; 2007 Sep 13; 28(18):2200-7. PubMed ID: 17673448
    [Abstract] [Full Text] [Related]

  • 17. Nonfatal aplastic anemia associated with clopidogrel.
    Uz O, Kardeşoğlu E, Aparci M, Yiğiner O, Işilak Z, Ozmen N.
    Anadolu Kardiyol Derg; 2010 Jun 13; 10(3):291. PubMed ID: 20538571
    [No Abstract] [Full Text] [Related]

  • 18. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar 13; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 19. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
    L'Allier PL, Aronow HD, Cura FA, Bhatt DL, Albirini A, Schneider JP, Topol EJ, Ellis SG.
    Can J Cardiol; 2003 Aug 13; 19(9):1041-6. PubMed ID: 12915931
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.